Status:
UNKNOWN
Evaluation of the Effects of Covid 19 Infection on Bone Remodeling and Bone Fragility
Lead Sponsor:
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Conditions:
Bone Remodeling Bone Fragility Resulting From Covid19
Eligibility:
All Genders
50+ years
Brief Summary
Although SARS-CoV-2 infection and subsequent COVID-19 disease is regarded as a disease that primarily affects the lungs, it can also damage many other organs. This organ damage may increase the risk o...
Detailed Description
The biological markers under study ( RANKL, OPG, RAGE) will be determined: \- The determinations will be performed on blood samples performed as part of the checks conducted in the normal diagnostic ...
Eligibility Criteria
Inclusion
- age greater than or equal to 50 years
- patients in the emergency room for fracture of the proximal femur
- subjects of both sexes
- pathologies related to bone fragility (osteoporosis, fractures, parathyroid pathologies).
- signature of the informed consent
- having performed the nasopharyngeal swab for clinical practice to check for SARS Cov2 infection
Exclusion
- previous conditions of hypovitaminosis D
- steroid therapy
- Presence of autoimmune diseases or that can create alterations in the inflammatory response
Key Trial Info
Start Date :
February 18 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05352295
Start Date
February 18 2021
End Date
December 31 2022
Last Update
April 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istituto Ortopedico Galeazzi
Milan, Italy